Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

por Çalışkan, Burcu, Sinoplu, Esra, İbiş, Kübra, Akhan Güzelcan, Ece, Çetin Atalay, Rengül, Banoglu, Erden
Publicado 2018

Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition

por Turanlı, Sümeyye, Ergül, Azize Gizem, Jordan, Paul M., Olğaç, Abdurrahman, Çalışkan, Burcu, Werz, Oliver, Banoglu, Erden
Publicado 2022

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

por Gur Maz, Tugce, Koc, Beyzanur, Jordan, Paul M., İbiş, Kübra, Çalışkan, Burcu, Werz, Oliver, Banoglu, Erden
Publicado 2023

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

por Turanlı, Sümeyye, Nalbat, Esra, Lengerli, Deniz, İbiş, Kübra, Güntekin Ergün, Sezen, Akhan Güzelcan, Ece, Muyan, Mesut, Cetin-Atalay, Rengul, Çalışkan, Burcu, Banoglu, Erden
Publicado 2022

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

por Saatci, Ozge, Akbulut, Ozge, Cetin, Metin, Sikirzhytski, Vitali, Uner, Meral, Lengerli, Deniz, O’Quinn, Elizabeth C., Romeo, Martin J., Caliskan, Burcu, Banoglu, Erden, Aksoy, Sercan, Uner, Aysegul, Sahin, Ozgur
Publicado 2023

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

por Gedik, Mustafa Emre, Saatci, Ozge, Oberholtzer, Nathaniel, Uner, Meral, Akbulut, Ozge, Cetin, Metin, Aras, Mertkaya, Ibis, Kubra, Caliskan, Burcu, Banoglu, Erden, Wiemann, Stefan, Uner, Aysegul, Aksoy, Sercan, Mehrotra, Shikhar, Sahin, Ozgur
Publicado 2023